F-group (family)
10.2.1.33 Pox_Rif
Ligands and drugs
166
Member domains
63
with ligand contacts (≤ 4 Å)
38.0% of members
47
with DrugDomain annotations
28.3% of members
34
with a DrugBank compound
20.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 10.2.1.33 belongs to X-group 10 jelly-roll, which binds 8.5 ligand superclasses per 20 proteins, broader than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00615 | RBT | Rifabutin | 6 |
| DB01045 | RFP | Rifampin | 6 |
| DB01201 | RPT | Rifapentine | 6 |
| DB01220 | RXM | Rifaximin | 6 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 3YI | (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-formyl-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate | 6 |
| RBT | RIFABUTIN | 6 |
| RFP | RIFAMPICIN | 6 |
| RFV | rifamycin SV | 6 |
| RPT | RIFAPENTINE | 6 |
| RXM | (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-25-yl acetate | 6 |